Portsmouth Hospitals University NHS Trust
Portsmouth, Hampshire, PO6 3LY, United Kingdom
NCT Number: NCT07828314
Understanding patient priorities is important to providing thorough, individualised care in oesophageal cancer. We aim to use questionnaires to explore what is important to patients when considering radical surgery for oesophageal cancer, and to analyse how patients interpret the risk explained to them during the consent process
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Portsmouth, Hampshire, PO6 3LY, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Interviews will be facilitated by the research team. The sessions will be designed to follow the consolidated criteria for reporting qualitative research (COREQ) (12). The Questionnaire on Distress in Cancer Patients and The Cancer Worry Scale (both validated patient surveys) were also used to help design the script for the interview. The full interview script can be found in a separate document entitled "Patient priorities in Oesophageal Cancer".
Participants will be asked to imagine the following scenario; "You have undergone endoscopic resection for an early oesophageal cancer. All your cancer has been removed, but the histology from your endoscopic resection shows you are at an increased risk of recurrence. This risk could be reduced by undergoing a radical oesophagectomy. The following options are presented to you;"
Time frame: 6 months
Interview responses and responses from discrete choice experiment.
Portsmouth Hospitals NHS Trust
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06277921
Digestive System Diseases, Digestive System Neoplasms
Minsk, Belarus
View Trial DetailsNCT03212469
Carcinoma, Carcinoma, Squamous Cell
Villejuif, Val De Marne, France
View Trial DetailsNCT04484636
Adenocarcinoma, Biliary Tract Diseases
Frankfurt am Main, Hesse, Germany
View Trial DetailsNCT05784597
Breast Cancer, Breast Diseases
Milan, Milano, Italy
View Trial Details